GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:GEHC • US36266G1076

82.63 USD
+3.85 (+4.89%)
At close: Feb 4, 2026
82 USD
-0.63 (-0.76%)
After Hours: 2/4/2026, 7:24:50 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GEHC. GEHC was compared to 186 industry peers in the Health Care Equipment & Supplies industry. GEHC has an excellent profitability rating, but there are concerns on its financial health. GEHC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • GEHC had positive earnings in the past year.
  • In the past year GEHC had a positive cash flow from operations.
  • In the past 5 years GEHC has always been profitable.
  • Each year in the past 5 years GEHC had a positive operating cash flow.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • GEHC has a Return On Assets of 6.14%. This is amongst the best in the industry. GEHC outperforms 85.48% of its industry peers.
  • GEHC has a better Return On Equity (22.19%) than 95.16% of its industry peers.
  • The Return On Invested Capital of GEHC (7.77%) is better than 83.87% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.80%.
Industry RankSector Rank
ROA 6.14%
ROE 22.19%
ROIC 7.77%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 10.95%, GEHC belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GEHC has grown nicely.
  • The Operating Margin of GEHC (13.52%) is better than 81.72% of its industry peers.
  • GEHC's Operating Margin has been stable in the last couple of years.
  • With a Gross Margin value of 40.80%, GEHC is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.52%
PM (TTM) 10.95%
GM 40.8%
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GEHC is destroying value.
  • GEHC has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, GEHC has an improved debt to assets ratio.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.88 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of GEHC (1.88) is comparable to the rest of the industry.
  • GEHC has a debt to FCF ratio of 7.38. This is a slightly negative value and a sign of low solvency as GEHC would need 7.38 years to pay back of all of its debts.
  • GEHC has a better Debt to FCF ratio (7.38) than 74.73% of its industry peers.
  • GEHC has a Debt/Equity ratio of 0.83. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
  • GEHC's Debt to Equity ratio of 0.83 is on the low side compared to the rest of the industry. GEHC is outperformed by 72.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 7.38
Altman-Z 1.88
ROIC/WACC0.79
WACC9.89%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • GEHC has a Current Ratio of 1.18. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GEHC has a worse Current ratio (1.18) than 80.65% of its industry peers.
  • GEHC has a Quick Ratio of 1.18. This is a bad value and indicates that GEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GEHC has a worse Quick ratio (0.95) than 77.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.95
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

  • GEHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.77%, which is quite good.
  • The Earnings Per Share has been growing slightly by 5.32% on average over the past years.
  • GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.52%.
  • The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.54% on average over the next years.
  • GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.87% yearly.
EPS Next Y3.45%
EPS Next 2Y5.89%
EPS Next 3Y7.69%
EPS Next 5Y7.54%
Revenue Next Year4.24%
Revenue Next 2Y4.29%
Revenue Next 3Y4.37%
Revenue Next 5Y3.87%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.00, GEHC is valued on the expensive side.
  • Based on the Price/Earnings ratio, GEHC is valued cheaply inside the industry as 86.56% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of GEHC to the average of the S&P500 Index (28.25), we can say GEHC is valued slightly cheaper.
  • GEHC is valuated correctly with a Price/Forward Earnings ratio of 16.41.
  • 88.17% of the companies in the same industry are more expensive than GEHC, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of GEHC to the average of the S&P500 Index (27.50), we can say GEHC is valued slightly cheaper.
Industry RankSector Rank
PE 18
Fwd PE 16.41
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaply inside the industry as 86.02% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 83.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.89
EV/EBITDA 12.75
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)5.21
PEG (5Y)3.38
EPS Next 2Y5.89%
EPS Next 3Y7.69%

More info and screens

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.18%, GEHC is not a good candidate for dividend investing.
  • GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.21. GEHC pays more dividend than 89.78% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, GEHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • GEHC pays out 2.80% of its income as dividend. This is a sustainable payout ratio.
DP2.8%
EPS Next 2Y5.89%
EPS Next 3Y7.69%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

More info and screens

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (2/4/2026, 7:24:50 PM)

After market: 82 -0.63 (-0.76%)

82.63

+3.85 (+4.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)02-04
Inst Owners89.01%
Inst Owner Change-1.22%
Ins Owners0.28%
Ins Owner Change-0.04%
Market Cap37.64B
Revenue(TTM)20.25B
Net Income(TTM)2.22B
Analysts79.29
Price Target93.55 (13.22%)
Short Float %2.38%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-09
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.23%
PT rev (3m)5.4%
EPS NQ rev (1m)0.82%
EPS NQ rev (3m)0.51%
EPS NY rev (1m)0.76%
EPS NY rev (3m)0.6%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.12%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 18
Fwd PE 16.41
P/S 1.86
P/FCF 26.89
P/OCF 20.35
P/B 3.77
P/tB N/A
EV/EBITDA 12.75
EPS(TTM)4.59
EY5.55%
EPS(NY)5.03
Fwd EY6.09%
FCF(TTM)3.07
FCFY3.72%
OCF(TTM)4.06
OCFY4.92%
SpS44.45
BVpS21.94
TBVpS-10.12
PEG (NY)5.21
PEG (5Y)3.38
Graham Number47.6
Profitability
Industry RankSector Rank
ROA 6.14%
ROE 22.19%
ROCE 10.51%
ROIC 7.77%
ROICexc 9.18%
ROICexgc 27.2%
OM 13.52%
PM (TTM) 10.95%
GM 40.8%
FCFM 6.91%
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 7.38
Debt/EBITDA 2.51
Cap/Depr 78.67%
Cap/Sales 2.22%
Interest Coverage 5.09
Cash Conversion 55.91%
Profit Quality 63.15%
Current Ratio 1.18
Quick Ratio 0.95
Altman-Z 1.88
F-Score5
WACC9.89%
ROIC/WACC0.79
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
EPS Next Y3.45%
EPS Next 2Y5.89%
EPS Next 3Y7.69%
EPS Next 5Y7.54%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
Revenue Next Year4.24%
Revenue Next 2Y4.29%
Revenue Next 3Y4.37%
Revenue Next 5Y3.87%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.38%
EBIT Next 3Y10.76%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 5 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 2.8%.